BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 30280765)

  • 1. Reduced expression of miR-564 is associated with worse prognosis in patients with osteosarcoma.
    Gao F; Xu F
    Eur Rev Med Pharmacol Sci; 2018 Sep; 22(18):5851-5856. PubMed ID: 30280765
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Down-regulation of microRNA-26a and up-regulation of microRNA-27a contributes to aggressive progression of human osteosarcoma.
    Taheriazam A; Bahador R; Karbasy SH; Jamshidi SM; Torkaman A; Yahaghi E; Shakeri M
    Diagn Pathol; 2015 Sep; 10():166. PubMed ID: 26377680
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Decreased microRNA-452 expression and its prognostic significance in human osteosarcoma.
    Li RZ; Wang LM
    World J Surg Oncol; 2016 May; 14():150. PubMed ID: 27193084
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prognostic value of microRNA-223/epithelial cell transforming sequence 2 signaling in patients with osteosarcoma.
    Zhang H; Yin Z; Ning K; Wang L; Guo R; Ji Z
    Hum Pathol; 2014 Jul; 45(7):1430-6. PubMed ID: 24784921
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Elevated expression of microRNA-19a predicts a poor prognosis in patients with osteosarcoma.
    Zou P; Ding J; Fu S
    Pathol Res Pract; 2017 Mar; 213(3):194-198. PubMed ID: 28214202
    [TBL] [Abstract][Full Text] [Related]  

  • 6. miR-21 predicts poor prognosis in patients with osteosarcoma.
    Ren X; Shen Y; Zheng S; Liu J; Jiang X
    Br J Biomed Sci; 2016 Oct; 73(4):158-162. PubMed ID: 27922432
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Decreased expression of miR-490-3p in osteosarcoma and its clinical significance.
    Tang B; Liu C; Zhang QM; Ni M
    Eur Rev Med Pharmacol Sci; 2017 Jan; 21(2):246-251. PubMed ID: 28165565
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Down-regulation of microRNA152 is associated with the diagnosis and prognosis of patients with osteosarcoma.
    Wang NG; Wang DC; Tan BY; Wang F; Yuan ZN
    Int J Clin Exp Pathol; 2015; 8(8):9314-9. PubMed ID: 26464682
    [TBL] [Abstract][Full Text] [Related]  

  • 9. MicroRNA34a is associated with chemotherapy resistance, metastasis, recurrence, survival, and prognosis in patient with osteosarcoma.
    Lian H; Zhou Y; Sun Z; Liu K
    Medicine (Baltimore); 2022 Sep; 101(38):e30722. PubMed ID: 36197268
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Combined microRNA-340 and ROCK1 mRNA profiling predicts tumor progression and prognosis in pediatric osteosarcoma.
    Cai H; Lin L; Cai H; Tang M; Wang Z
    Int J Mol Sci; 2014 Jan; 15(1):560-73. PubMed ID: 24398981
    [TBL] [Abstract][Full Text] [Related]  

  • 11. XB130 expression in human osteosarcoma: a clinical and experimental study.
    Wang X; Wang R; Liu Z; Hao F; Huang H; Guo W
    Int J Clin Exp Pathol; 2015; 8(3):2565-73. PubMed ID: 26045762
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tissue microRNA-126 expression level predicts outcome in human osteosarcoma.
    Liu W; Zhao ZY; Shi L; Yuan WD
    Diagn Pathol; 2015 Jul; 10():116. PubMed ID: 26194657
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Serum miR-542-3p as a prognostic biomarker in osteosarcoma.
    Li Q; Song S; Ni G; Li Y; Wang X
    Cancer Biomark; 2018 Feb; 21(3):521-526. PubMed ID: 29103020
    [TBL] [Abstract][Full Text] [Related]  

  • 14. miR-497 as a potential serum biomarker for the diagnosis and prognosis of osteosarcoma.
    Pang PC; Shi XY; Huang WL; Sun K
    Eur Rev Med Pharmacol Sci; 2016 Sep; 20(18):3765-3769. PubMed ID: 27735043
    [TBL] [Abstract][Full Text] [Related]  

  • 15. MicroRNA-1908 is a biomarker for poor prognosis in human osteosarcoma.
    Lian D; Wang ZZ; Liu NS
    Eur Rev Med Pharmacol Sci; 2016 Apr; 20(7):1258-62. PubMed ID: 27097944
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prognostic significance of relaxin-2 and S100A4 expression in osteosarcoma.
    Huang H; Zheng HY; Liu ZL; Zhang L
    Eur Rev Med Pharmacol Sci; 2014 Oct; 18(19):2828-34. PubMed ID: 25339476
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Downregulation of miR-22 acts as an unfavorable prognostic biomarker in osteosarcoma.
    Wang G; Shen N; Cheng L; Lin J; Li K
    Tumour Biol; 2015 Sep; 36(10):7891-5. PubMed ID: 25953260
    [TBL] [Abstract][Full Text] [Related]  

  • 18. MicroRNA-335 and its target Rock1 synergistically influence tumor progression and prognosis in osteosarcoma.
    Wang Y; Wang N; Zeng X; Sun J; Wang G; Xu H; Zhao W
    Oncol Lett; 2017 May; 13(5):3057-3065. PubMed ID: 28521412
    [TBL] [Abstract][Full Text] [Related]  

  • 19. MiR-451 inhibits cell growth and invasion by targeting CXCL16 and is associated with prognosis of osteosarcoma patients.
    Zhang F; Huang W; Sheng M; Liu T
    Tumour Biol; 2015 Mar; 36(3):2041-8. PubMed ID: 25391425
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Serum microRNA-221 functions as a potential diagnostic and prognostic marker for patients with osteosarcoma.
    Yang Z; Zhang Y; Zhang X; Zhang M; Liu H; Zhang S; Qi B; Sun X
    Biomed Pharmacother; 2015 Oct; 75():153-8. PubMed ID: 26422796
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.